David B. Rheingold


David B. Rheingold specializes in an active trial practice primarily involving drug product and medical device liability cases. He is the managing partner for the firm’s cases in the $2.5 billion DePuy ASR metal-on-metal hip implant settlement plan; the $1.4 billion Stryker Rejuvenate metal-on-metal hip implant settlement plan; $300 million Benicar Olmesartan settlement plan; and the $100 million NuvaRing settlement program.

He uses his medical expertise in preparing the firm's "Extraordinary Injury" and "Enhanced Injury" claims for recent medical device litigations: Medtronic Defibrillator, Guidant Defibrillator, Medtronic Sprint Fidelis Lead litigations, DePuy ASR hip implants, Stryker Rejuvenate hip implants and Benicar Olmesartan hypertension drug. The Rheingold firm had leadership positions in Medtronic and Guidant litigations which settled for $118 million, $195 million and $268 million respectively.

Since joining our firm in 1995, he has concentrated on the mass tort cases, most recently implantable medical devices and prescription drugs, in both federal and state courts. Recently launched litigations are IVC filters, Talcum Powder, Taxotere, Bair Hugger forced air warming blankets, and Invokana diabetes medication.

On both a local and national level, he has obtained substantial client settlements through arbitration, mediation and direct negotiations with some of the largest national and international drug and medical device makers. Prior to joining the firm, David practiced in Virginia handling personal injury cases

Current litigations include many medical implants: Biomet M2a, DePuy ASR & Pinnacle, Stryker, Wright Medical, and Zimmer. For knee implants, he litigates in federal court these knee implants: Zimmer NexGen, Zimmer Persona, DePuy Attune and Exactech Optetrak. A large part of his time is devoted to litigating hernia and pelvic mesh cases in state and federal courts against the following defendants: AMS, Bard, Boston Scientific, Coloplast, Ethicon, and Gynemesh. Drug litigation is also a large part of his federal and state practice and includes: Benicar (appointed to the Benicar Multidistrict Litigation Plaintiffs’ Steering Committee, the Bellwether Litigation Committee, as well as the Document Review Committee), Yaz/Yasmin/Beyaz, NuvaRing, Fosamax, Actonel, Boniva, Heparin, Levaquin, and Reglan. His direct involvement in management of specific litigations includes courts in New York, New Jersey, and federal courts throughout the United States.

As an active member in the American Association for Justice, City Bar Association of New York, and the New York State Trial Lawyers, and the New York Trial Academy, he has access to litigation resources and materials throughout the United States. His is the co-chair for the Fosamax and Other Bisphosphonates Litigation Group. This local and national experience makes him a valuable lecturer to other trial attorneys on handling mass tort cases, and he provides annual lectures to New York State Trial Lawyers at the annual "Decisions" seminars throughout New York State. He is an annual guest lecturer at New York School of Law and the Michigan State University School of Law. He also guest lectures to lawyers at the Attorneys Exchange Information Group.

He believes strongly in “giving back” to the community and has created the Mentor First intern program which is a community-based mentorship program for first generation and foreign students who want to intern for a hands-on law firm experience.

He has management responsibilities at the firm, including publishing the firm’s newsletters. Also, he directs our firm's public service news reporting on these firm website areas: Medical Malpractice Blog, Negligence Blog, Articles, "Greed & Misdeeds" section, and Spanish content.

He has been long-time supporter of the arts, having been a co-founder and producer of Salon Ciel http://saloncielny.org/, aand the Take Two Film Festival. http://www.taketwofilmfestival.com/david-rheingold/

David can be e-mailed directly at drheingold@rheingoldlaw.com.

Areas of Practice

  • Active Trial Practice
  • Drug Product
  • Medical Device Liability Cases
  • Mass Tort Cases
  • Personal Injury Cases


  • Lecturer, New York State Trial Lawyers annual "Decisions" seminars throughout New York State, as well as law school torts classes

Litigation Percentage

  • 100% of Practice Devoted to Litigation

Year Joined Firm

  • 1995

Bar Admissions

  • New York, 1994
  • New Jersey
  • Virginia, 1988
  • U.S. District Court Southern District of New York, 1994
  • U.S. District Court Eastern District of New York, 1994


- Rated by SuperLawyers 2015

- Rated by SuperLawers 5 Years


  • University of Richmond, The T.C. Williams School of Law, Richmond, Virginia
    • J.D. - 1988
  • Oberlin College, Oberlin, Ohio
    • B.A. - 1984
    • Major: Sociology

Professional Associations and Memberships

  • American Association for Justice, Member
  • City Bar Association of New York, Member
  • New York State Trial Lawyers, Member
  • Fosamax and Other Bisphosphonates Litigation Group, Co-Chair

Awards & Accolades

Don't Settle

for an Average Attorney
    • Please enter your name.
    • This isn't a valid phone number.
    • Please enter your email address.
      This isn't a valid email address.
    • Please make a selection.
    • Please enter a message.
Get RGRP On Your Side